To what extent is the variation in cardiac rehabilitation quality associated with patient characteristics? by Salman, Ahmad & Doherty, Patrick
This is a repository copy of To what extent is the variation in cardiac rehabilitation quality 
associated with patient characteristics?.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/140764/
Version: Published Version
Article:
Salman, Ahmad and Doherty, Patrick orcid.org/0000-0002-1887-0237 (2019) To what 
extent is the variation in cardiac rehabilitation quality associated with patient 
characteristics? BMC Health Services Research. ISSN 1472-6963 
https://doi.org/10.1186/s12913-018-3831-1
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
This article is distributed under the terms of the Creative Commons Attribution (CC BY) licence. This licence 
allows you to distribute, remix, tweak, and build upon the work, even commercially, as long as you credit the 
authors for the original work. More information and the full terms of the licence here: 
https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
RESEARCH ARTICLE Open Access
To what extent is the variation in cardiac
rehabilitation quality associated with
patient characteristics?
Ahmad Salman1,2* and Patrick Doherty1
Abstract
Background: Huge variability in quality of service delivery of cardiac rehabilitation (CR) in the UK. This study aimed
to ascertain whether the variation in quality of CR delivery is associated with participants’ characteristics.
Methods: Individual patient data from 1 April 2013 to 31 March 2014 were collected electronically from the UK’s
National Audit of Cardiac Rehabilitation database. Quality of CR delivery is categorised as low, middle, and high based
on six service-level criteria. The study included a range of patient variables: patient demographics, cardiovascular risk
factors, comorbidities, physical and psychosocial health measures, and index of multiple deprivation.
Results: The chance that a CR patient with more comorbidities attended a high-quality programme was 2.13 and 1.85
times higher than the chance that the same patient attended a low- or middle-quality programme, respectively.
Patients who participated in high-quality CR programmes tended to be at high risk (e.g. increased waist size and high
blood pressure); high BMI, low physical activity levels and high Hospital Anxiety and Depression Scale scores; and were
more likely to be smokers, and be in more socially deprived groups than patients in low-quality programmes.
Conclusions: These findings show that the quality of CR delivery can be improved and meet national standards by
serving a more multi-morbid population which is important for patients, health providers and commissioners of
healthcare. In order for low-quality programmes to meet clinical standards, CR services need to be more inclusive in
respect of patients’ characteristics identified in the study. Evaluation and dissemination of information about the
populations served by CR programmes may help low-quality programmes to be more inclusive.
Keywords: Cardiac rehabilitation, Quality of care and outcomes, Delivery of care, Observational study
Background
Cardiovascular disease (CVD) remains the leading cause
of death globally and is one of the most common causes
of long-term disability [1]. One in three deaths world-
wide are the result of CVD, yet most cases are prevent-
able. Cardiovascular disease is also a major contributor
to health inequity in the United Kingdom (UK) [2].
Cardiac rehabilitation (CR) is a multicomponent inter-
vention that targets risk factors and psychosocial well-
being and that is delivered by skilled multidisciplinary
teams [3]. Mounting evidence from robust trials and
registry data indicate that CR is clinically beneficial and
cost effective, with multifaceted secondary prevention
services resulting in decreased cardiovascular morbidity
and mortality in patients with CVD [4–8]. Cardiac rehabili-
tation is also recommended by the European Association of
Preventive Cardiology and the British Association for Car-
diovascular Prevention and Rehabilitation (BACPR) [3, 9].
The British Heart Foundation’s National Audit of Car-
diac Rehabilitation (NACR) collects data on service deliv-
ery and patient outcomes [10]. In 2015, the BACPR and
NACR developed the National Certification programme
for Cardiovascular Rehabilitation (NCP_CR) which set out
to improve delivery of CR, showcase good services, and
seek to ensure the effectiveness of routine provision of CR
programmes through achievement of a minimum level
of service delivery across the UK [3, 10, 11]. Cardiac
rehabilitation in the UK is delivered to groups of patients
in healthcare or community centres using a mixture of
* Correspondence: drahmadq8@gmail.com
1Department of Health Sciences, University of York, York, UK
2Ministry of Health, Kuwait City, Kuwait
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Salman and Doherty BMC Health Services Research            (2019) 19:3 
https://doi.org/10.1186/s12913-018-3831-1
supervised or unsupervised approaches conducted in
any setting (inpatient, outpatient, community, home
based) [12]. Most CR programmes comprise weekly
attendance at group sessions for an average of 63 days
or 9 weeks [10].
Despite the strong evidence-based standards for ser-
vice delivery of CR, it has become apparent from recent
NACR reports and journal publications that CR is not
delivered equitably across the UK [10, 13]. There are dif-
ferences at programme level either defined by NCP_CR
or local variation [10, 13]. However, the role played by
patient characteristics in associating whether the quality
of delivery of CR services is high, medium, or low re-
mains unclear [10, 13]. Moreover, continued debate in
the literature suggests that some CR programmes are
suboptimal in terms of delivery, are less effective, and
might not achieve expected outcomes [12, 14–16]. It is
important to investigate whether the populations attend-
ing CR programmes are the same across the three qual-
ity categories of CR. The aim of this study was to
ascertain whether the variation in CR quality is associ-
ated with the participating patients’ characteristics.
Methods
This study follows the Strengthening the Reporting of
Observational Studies in Epidemiology (STROBE) guide-
lines [17].
Data collection
Analyses were conducted using individual patient data
collected electronically in the NACR database from 1
April 2013 to 31 March 2014; this relates to the first year
in which the NCP-CR minimum performance criteria,
which use national averages reported by the NACR, were
in place to audit the delivery of CR [11, 18]. National
Health Service (NHS) Digital has approval to collect
patient-identifiable data which are then removed before
any data extract made available to the NACR team [19].
This data governance process removes the need for expli-
cit consent from individual patients for the purposes of
audit and service related research under Section 251 of
the NHS Act 2006. The audit is voluntary and supports
direct entry of data within a secure online system, collect-
ing local programme-level data on the delivery of CR
alongside patient-level data for those who are referred to
and undergo CR. Only clinically approved users, verified
through a Caldicott Guardian, are able to input data. This
includes details of a patient’s initiating event, type of treat-
ment, risk factors, medications, demographics, and clinical
outcomes before and after CR. NACR data governance
approval is reviewed annually by NHS Digital. So long as
the data is used for valid NACR purposes and works
within agreed data protection processes then separate eth-
ical approval is not required. Patients were included in
our study if they started CR, had been assessed at baseline,
and had follow-up data at an assessment after CR.
Procedure
This study used the methods reported in a previous study
[13], to categorise the quality of delivery of CR programmes
as low, middle, and high based on six service-level criteria.
The previous study was designed to assess the extent by
which CR programmes met six service-level NCP_CR
measures deemed important for the delivery of high-quality
rehabilitation: (1) whether CR is delivered to at least four
priority groups, (2) assessing before and (3) after CR, and
(4) whether rehabilitation of sufficient duration is delivered
(5) in a timely manner for myocardial infarction or percu-
taneous coronary intervention or (6) coronary artery bypass
surgery patients [13]. Our study used a variety of different
patient variables collected by the NACR [18], including
demographic characteristics, cardiovascular risk factors,
comorbidities, and physical and psychosocial health mea-
sures. To evaluate the role of social deprivation, the study
included the English Index of Multiple Deprivation (IMD),
which linked to the NACR. The IMD is an overall relative
measure of deprivation constructed by combining seven
domains of deprivation—income; employment; education,
skills and training; health and disability; crime; barriers to
housing and services; and living environment—according
to their respective weights [20]. The IMD provided Lower
Layer Super Output Areas (LSOA) and published
deprivation ‘deciles’ alongside ranks [20]. These deciles are
calculated by ranking the 32,844 sub-areas in England from
the most deprived to the least deprived and dividing them
into 10 equal groups [20]. These groups are ranked from 1
to 10, where 1 means that that the LSOA is among the
most deprived 10% nationally and 10 represents the least
deprived 10%.
Risk stratification published by the BACPR is a multi-
factorial measure used to establish prognosis of future
major cardiac events or exercise complications by utilising
all relevant patient information (e.g. left ventricular ejec-
tion fraction, history of arrhythmia, symptoms, functional
capacity) to determine the level of exercise intensity
prescribed and supervision required [3, 21]. High-risk
patients were defined as those at high-risk for cardiovas-
cular events during exercise training. Adaptations should
be made to the CR programme according to their risk
stratification and comorbidities. Given the level of risk
stratification, high risk patients need rigorous individual
assessment and risk profiling to be coupled with appropri-
ate monitoring and a safe management and delivery sys-
tem when undertaking exercise training [21].
Statistical analysis
Cardiac rehabilitation programmes were aggregated to
identify those that met the minimum NCP_CR criteria.
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The quality of delivery of CR programmes was cate-
gorised into three groups: scores of 5–6 represented
high quality, scores of 3–4 represented middle quality,
and scores of 1–2 represented low quality. Baseline com-
parisons between the three categories of CR delivery
quality were analysed using a one-way analysis of vari-
ance (ANOVA) for continuous variables. Effect sizes are
reported as partial eta squared (η2). Two multinomial
logistic regression models were used to test for inde-
pendent predictors of high quality in the delivery of CR,
using the high quality category as the reference. Vari-
ables were considered in the models according to their
association with the three CR quality categories [22], so
cardiovascular risk factors such as body mass index
(BMI) and comorbidity variables such as the mean num-
ber of comorbidities and the proportion of patients with
diabetes, stroke and asthma were considered in the final
model to address the aim of identifying higher level
quality criteria in the delivery of CR. A p value ≤0.05
was considered statistically significant. All data were
analysed using IBM SPSS Statistics 24 (New York, USA).
Results
A one-way ANOVA was conducted to determine whether
the mean value of each of the baseline patient characteris-
tics differed between categories of delivery quality (Table
1). No significant differences in age, gender, employment
status or IMD were noted between the three categorises.
In the high-quality programmes, patients at baseline
tended to be in the most deprived 10% nationally com-
pared to those in the low- and middle-quality programmes.
One-way ANOVA was also conducted to determine
whether there were differences in baseline health status
between the three categories of service delivery (Table
1). Body mass index differed significantly among the cat-
egories. The CR programmes with high-quality delivery
included more patients at higher risk—higher BMI and
waist circumference, high blood pressure (> 140/90
mmHg), more patients who smoke, and more severe
anxiety or depression—at enrolment than low-quality
programmes. Patients in high-quality programmes also
had poorer physical capacity and lower self-reported
physical activity status at baseline.
One-way ANOVA of the proportion of patients with a
comorbidity at baseline showed that the mean total of
comorbidities and proportion of patients with both dia-
betes and claudication differed significantly between the
three service delivery performance categories (Table 2).
Tables 3 and 4 outlines the results of the two multi-
nomial logistic regression models. We included all baseline
parameters that were statistically significant according to
ANOVA. The first regression was performed to ascertain
Table 1 Demographics and baseline health states of patients in cardiac rehabilitation (CR) programmes classified as having low-,
middle- and high-quality service delivery
Quality category p Value Effect size
Low (N) Middle (N) High (N)
Demographics
Age (years) 63.94 (31) 64.25 (78) 64.64 (52) 0.33 0.01
Female (%) 25.64 (30) 26.01 (77) 26.89 (52) 0.59 0.01
Unemployment (%) 15.96 (20) 19.27 (65) 17.78 (48) 0.56 0.01
IMD (mean) 6.23 (24) 5.90 (66) 5.86 (46) 0.57 0.01
Baseline health state
High risk (%) 16.28 (12) 21.84 (53) 23.39 (45) 0.32 0.02
BMI (kg/m2) (mean) 27.49 (30) 28.02 (77) 28.39 (51) 0.04* 0.04
Waist (cm) (mean) 97.47 (25) 98.07 (63) 101.00 (44) 0.44 0.01
BP 140 / 90 (%) 28.69 (25) 32.64 (70) 33.47 (52) 0.24 0.02
Smoker (%) 8.32 (18) 12.68 (60) 11.39 (48) 0.09 0.04
6MWT (metres) (mean) 342.74 (13) 276.66 (27) 280.61 (25) 0.15 0.06
ISWT (metres) (mean) 374.58 (7) 326.18 (30) 352.33 (25) 0.62 0.02
150 min moderate/week (%) 36.49 (31) 28.04 (76) 29.53 (52) 0.12 0.03
75min vigorous/week (%) 8.38 (30) 6.20 (76) 6.56 (52) 0.31 0.02
HADS anxiety (%) 28.05 (18) 32.58 (68) 31.54 (50) 0.16 0.03
HADS depression (%) 18.24 (17) 21.89 (66) 21.69 (50) 0.22 0.02
N, number of CR programmes; %, proportion of patients; BP blood pressure, BMI body mass index, HADS Hospital Anxiety and Depression Scale, IMD Index of
Multiple Deprivation, ISWT Incremental Shuttle Walk Test, 6MWT Six-Minute Walk Test. %, proportion of patients, BP blood pressure, BMI body mass index, HADS
Hospital Anxiety and Depression Scale, ISWT Incremental Shuttle Walk Test, 6MWT Six-Minute Walk Test
*p ≤ 0.05
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the effects of BMI and mean number of comorbidities at
baseline on the likelihood that programmes categorised as
high quality.
The model was based on 158 CR programmes (Low =
30, middle = 77, High = 51) with complete data. The
model was statistically significant: χ2(4) = 14.05 (p = 0.01).
Of the two predictor variables, both were statistically
significant (Table 3).
Increasing mean BMI and number of total comor-
bidities were associated with a decrease in the odds
of being in the low-quality service delivery category
compared to high category, with an odds ratio of 0.67
(95% Confidence Interval (CI) (0.49, 0.93)) and 0.47
(95% CI (0.24, 0.90)), respectively.
The second regression was performed to ascertain the
effects of components of comorbidities: proportion of
patients with diabetes, stroke and asthma at baseline on
the likelihood that that programmes categorised as high
quality. The model was based on the 161 CR quality
programmes (Low = 31, middle = 78, High = 52) with
Table 2 Baseline comorbidity profiles of patients in cardiac rehabilitation (CR) programmes classified as having low-, middle- and
high-quality service delivery
Comorbidity Quality category p Value Effect size
Low (31) Middle (78) High (52)
Total comorbidities (mean) 1.36 1.44 1.72 0.05* 0.04
Angina % 12.23 12.07 14.38 0.43 0.01
Arthritis % 7.94 9.72 11.42 0.13 0.03
Cancer % 2.99 4.32 4.73 0.10 0.03
Diabetes % 9.99 13.93 15.90 0.01* 0.06
Rheumatism % 1.77 1.61 2.09 0.43 0.01
Stroke % 2.07 3.28 3.79 0.01* 0.06
Osteoporosis % 1.08 1.27 1.86 0.05 0.04
Hypertension % 31.89 31.87 35.58 0.47 0.01
Chronic bronchitis (COPD) % 1.22 3.04 2.55 0.54 0.01
Emphysema % 0.53 1.50 1.80 0.13 0.03
Asthma % 4.59 4.65 6.55 0.01* 0.06
Claudication % 3.07 1.47 2.41 0.19 0.02
Chronic back problems % 5.02 6.58 8.33 0.12 0.03
Anxiety % 4.78 1.96 2.82 0.29 0.02
Depression % 4.92 2.73 3.20 0.48 0.01
Family history of CVD % 9.58 11.28 11.69 0.74 0.00
Hypercholesterolaemia or dyslipidaemia % 17.21 15.58 18.74 0.56 0.01
% proportion of patients, COPD chronic obstructive pulmonary disease, CVD cardiovascular disease
*p ≤ 0.05
Table 3 Multinomial regression models for independent
predictors of category of quality for CR delivery
Measured variables b (SE) Lower Odds ratio Upper
Low- vs high-quality categories
Intercept 11.86 (4.69)*
Mean total comorbidities −0.76 (0.34)* 0.24 0.47 0.90
BMI −0.40 (0.17)* 0.49 0.67 0.93
Middle- vs high-quality categories
Intercept 7.71 (4.15)
Mean total comorbidities −0.62 (0.26)* 0.32 0.54 0.90
BMI −0.22 (0.15) 0.60 0.80 1.06
BMI body mass index, b regression coefficients, SE standard error
*p ≤ 0.05
Table 4 Multinomial regression models for independent
predictors of category of quality for CR delivery
Measured variables b (SE) Lower Odds ratio Upper
Low- vs high-quality categories
Intercept 1.19 (0.52)*
Diabetes (%) −0.09 (0.05)* 0.83 0.91 0.99
Stroke (%) −0.24 (0.13) 0.62 0.79 1.01
Asthma (%) 0.03 (0.09) 0.87 1.03 1.23
Middle- vs high-quality categories
Intercept 1.27 (0.44)*
Diabetes (%) −0.01 (0.03) 0.95 1.00 1.05
Stroke (%) 0.05 (0.09) 0.88 1.05 1.25
Asthma (%) −0.17 (0.07)* 0.74 0.84 0.96
% proportion of patients, b regression coefficients, SE standard error
*p ≤ 0.05
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complete data. The model was statistically significant,
χ2(6) = 24.79 (p < 0.001). Of the three predictor variables,
two were statistically significant: proportion of diabetes
comorbidity and proportion of asthma comorbidity
(Table 4).
Increasing mean proportion of patients with diabetes
comorbidity was associated with a decrease in the odds
of being in the low-quality compared to high category,
with an odds ratio of 0.91 (95% CI (0.83, 0.99)). An
increase in mean proportion of patients with asthma co-
morbidity was associated with a decrease in the odds of
being in the middle-quality compared to high category,
with an odds ratio of 0.84 (95% CI (0.74, 0.96)).
Discussion
There were significant differences in the patient popula-
tion between the quality categories for delivery of CR
services. Previous research that examined the quality of
delivery of CR programmes in the UK identified three
distinct categories and proportions—low (30.6%), middle
(45.9%), and high (18.2%) of CR quality [13]. We investi-
gated whether the three quality categories differed with
regard to the populations being treated within them. A
CR programme was more likely to be categorised as high
quality if it included patients with a higher mean total of
comorbidities, including diabetes, stroke, and asthma in
addition to high BMI.
According to our findings, high-quality programmes
recruit more patients with multiple comorbidities, who
are more representative of the broader CVD population
than those with few comorbidities. The presence of mul-
tiple comorbidities including stroke, diabetes, chronic
obstructive pulmonary disease is an important factor
associated with a lower likelihood of a patient being
referred to and participating in CR [23–26], and the
authors of a systematic review warned that CR pro-
grammes need to pay greater attention to recruitment of
patients with multiple morbidities [4]. However, patients
with multiple morbidities represent populations at sig-
nificantly increased cardiovascular risk who may benefit
from the services provided in CR [23–26].
For one additional comorbidity, the odds of being in
the high-quality service increases by a factor of 2.13 as
opposed to low quality and by a factor of 1.85 as opposed
to middle quality, which indicates that high-quality CR
programmes take on more complicated cases and poten-
tially higher risk patients than low or middle-quality
programmes. The presence of multiple comorbidities is an
important factor associated with lower odds of referral to,
participation in, and uptake of CR [23–26]. The high-qual-
ity CR programmes included more patients with the most
dominant morbidities associated with CVD according to
the NACR [10]— hypertension, hypercholesterolaemia or
dislipidaemia, diabetes, angina, combination of respiratory
conditions (chronic bronchitis, emphysema, and asthma),
arthritis, chronic back problems, cancer, stroke,—at entry
to CR than the low-quality programmes.
For each unit increase in the BMI, the odds of being
in the high-quality category increases by a factor of 1.49
as opposed to low quality. Obesity is an independent risk
factor for the development of CVD [27] and higher BMI
was associated with shorter longevity and significantly
increased risk of cardiovascular morbidity and mortality
compared with normal BMI [28]. At entry into CR,
more than 80% of patients are overweight and 30% have
BMI > 30 kg/m2 [10, 29]. Cardiac rehabilitation pro-
grammes do not generally include weight-loss compo-
nents [29], but CR programmes with high-quality
delivery recruit more patients with CVD and higher
BMI than those with low-quality delivery.
For each percent increase in the proportion of patients
with diabetes comorbidity, the odds of being in the
high-quality category increases by a factor of 1.10 as op-
posed to low quality. Despite the fact that CVD is the
most prevalent cause of mortality and morbidity in
diabetic populations [30] and in addition to the fact that
patients with diabetes had more CVD risk factors and
lower physical capacity than patients without diabetes at
the beginning of CR [30, 31], the findings show that
high-quality programmes recruit more patients with
CVD and diabetes than low-quality programmes. Previ-
ous studies have examined the benefit of CR in diabetes
[32, 33]. Cardiac rehabilitation patients with diabetes
comorbidity emphasizes the need to target diabetic pa-
tients in CR programs for an aggressive program of risk
factor management [31]. The prevalence of diabetic
patients in CR programs appears to be increasing, and is
likely to continue to rise as the current trends indicating
increase of prevalence of diabetes [31]. Diabetic patients
are more depressed following CVD and have lower
scores for functional status, well-being, and total quality
of life than non-diabetic patients [34]. Cardiac rehabilita-
tion in diabetic patients results in marked reduction in
depression to a prevalence rate identical to non- diabetic
patients in addition to improvements in exercise cap-
acity and total quality of life following CR [34].
For each percent increase in the proportion of patients
with asthma comorbidity, the odds of being in the
high-quality category increases by a factor of 1.19 as op-
posed to middle quality. The findings show that high-
quality programmes recruit more patients with CVD
and asthma than low- and middle- quality programmes.
Asthma is one of the global morbidity and is the most
common chronic respiratory diseases worldwide and it
was prospectively associated with increased risk of major
CVD [35, 36]. Recent meta-analysis results indicate that
asthma was associated with an increased risk of CVD
and all-cause mortality in cohort studies [37]. Large
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cohort studies provide more evidence that asthmatics
have a higher CVD event rates and an increased risk of
death than non-asthmatics [38, 39]. Comorbidity asthma
was associated with a decreased likelihood of CR attend-
ance among cardiac patients [40].
The results of the analysis of social deprivation showed
no statistically significant difference in social deprivation
among quality categories, high-quality programmes
tended to recruit more socially deprived patients than
low- and middle-quality programmes. Previous studies
suggested that socioeconomic deprivation is associated
with lower participation in CR, as non-participants tend
to be more socially deprived [41–43]. A systematic
review showed that patients with greater deprivation are
less likely to attend CR programmes but may have the
most to gain from CR because of a linear relation be-
tween socioeconomic status and cardiac outcomes [44].
Patients who participated in high-quality CR pro-
grammes tended to be those with high-risk status, high
BMI score, high waist circumference, and high blood
pressure, high HADS anxiety and depression score,
smokers; to have more comorbidities; and to be in more
socially deprived groups than patients in the low-quality
programmes. In addition, high-quality CR programmes
also take on patients with lower fitness levels than
low-quality programmes. Such patients often have more
severe functional impairment and are most in need of
CR, as well as being most likely to benefit [45].
Ensuring equity of access to CR and improving the
consistency of delivery should increase long-term behav-
iour changes and contribute to a reduction in CVD-related
health inequality [46]. The data analysis shows that there
are significant differences between low-, middle and
high quality of CR programme in staffing or number
of qualified multidisciplinary team (MDT) as a surro-
gate for well-resourced programmes. 63% of CR pro-
grammes in the low-quality programmes comprise of
at least three different professions in the CR team
while 73.7 and 85.4% of middle and high quality pro-
grammes delivered by MDT (3+) respectively.
Although the BACPR recommends staffing to be
multi-disciplinary [3], some CR programmes have vary-
ing staffing and less physical resource (equipment and
location space) which can impact on patient recruit-
ment. In addition, around 20% of CR programmes don’t
carry out formal assessment at baseline which again may
influence the type of patients they receive [10]. Patient
choice is a reality in the UK where patients can ask to
be referred to a CR programme not associated with their
local hospital.
This is the only UK-specific study to ascertain whether
the variation in quality of CR delivery is, in-part, deter-
mined by the patient characteristics, while also address-
ing whether these differences are associated with better
quality delivery. This study accounted for the range of
patients within programmes in terms of demographic
characteristics, cardiovascular risk factors, comorbidities,
and physical and psychosocial health measures collected
by the NACR. Evaluation and dissemination of informa-
tion about the populations served by CR programmes
may help low-quality programmes to be more inclusive.
Strengths and limitations of this study
The use of an observational approach based on volun-
tary and routinely collected patient data is a strength in
respect of real-world representation. According to the
2017 NACR report [10], only 224 of the 303 CR pro-
grammes in the UK entered data electronically to the
NACR. It can be argued that this provided enough data
to be representative and to carry out a reliable analysis,
but future studies should aim to achieve greater capture
of available patient records across the UK.
Conclusions
This study aimed to ascertain whether the variation in
quality of CR delivery is associated with patients’ charac-
teristics. Mean total comorbidities, higher BMI scores,
proportion of patients with diabetes or asthma were as-
sociated with CR programmes categorised as high qual-
ity. This finding shows that the quality of delivery of a
CR programme is associated with the morbidity profile
of its patient population. The quality of CR delivery can
be improved and meet national standards by serving a
more multi-morbid population which is important for
patients, health providers and commissioners of health-
care. In order for low-quality programmes to meet clin-
ical standards, CR services need to be more inclusive in
respect of patients’ characteristics identified in the study.
Further research is required to investigate the extent of
patient outcomes between high-quality, middle quality
and low-quality CR programmes in addition to investi-
gate CR programmes’ characteristics and the impact of
program location on quality.
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